Berberine promotes the degradation of phenylacetic acid to prevent thrombosis by modulating gut microbiota
Hao-Jian Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hang Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hengtong Zuo(Chinese Academy of Medical Sciences & Peking Union Medical College), Meng-Meng Bu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin‐Yue Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Fu(Tianjin University), Jia-Chun Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Wang(Nanchang University), Jian‐Ye Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingyue Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhao Zhai(Chinese Academy of Medical Sciences & Peking Union Medical College), Meng-Liang Ye(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 14
Related Papers
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
Alkaloids from the Root of <i>Isatis indigotica</i>
|Journal of Natural Products|2012|167
Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes
|Journal of Translational Medicine|2011|104